LENSAR, Inc. (LNSR) Tops Q4 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 3, 2022 7:00 AM EST
2021 Revenue Increases $8.1 million or 31% over 2020 Levels
Procedure Volume Increases over 2020 Levels by 37% in Fourth Quarter and by 35% in 2021
Cash and Cash Equivalents of $31.6 Million Reflect Cash Utilization of $0.7 Million in the Fourth Quarter
ORLANDO, Fla.--(BUSINESS WIRE)-- LENSAR, Inc. (Nasdaq: LNSR) (LENSAR or the Company), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced financial results for the quarter and full year ended December 31, 2021 and provided an update on key strategic and operational... More
